Your browser doesn't support javascript.
loading
Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.
Yilmaz, Mesut; Yasar, Canan; Aydin, Selda; Derin, Okan; Ceylan, Bahadir; Mert, Ali.
Afiliação
  • Yilmaz M; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey. myilmaz@medipol.edu.tr.
  • Yasar C; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey.
  • Aydin S; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey.
  • Derin O; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey.
  • Ceylan B; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey.
  • Mert A; Department of Infectious Diseases and Clinical Microbiology, Medipol Mega Hospital Complex, Istanbul Medipol University, TEM Avrupa Otoyolu Goztepe Cikisi No: 1, Bagcilar, 34214, Istanbul, Turkey.
Drug Saf Case Rep ; 5(1): 9, 2018 Feb 09.
Article em En | MEDLINE | ID: mdl-29427095
ABSTRACT
We present a 35-year-old female patient who was started on rifampicin (900 mg orally once daily) and trimethoprim/sulfamethoxazole (TMP/SMX) (160/800 mg orally twice daily) after being diagnosed with brucellosis. Following defervescence and improvement in her general condition, fever recurred on the 12th day of treatment. A re-challenge drug test lead to causality assessment and treatment was switched to a combination of streptomycin (1 g intramuscularly) for 10 days and TMP/SMX (160/800 mg orally twice daily) for 4 weeks. Our patient is doing well after 12 months of follow-up.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Drug Saf Case Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Drug Saf Case Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia